Novel Receptor for Advanced Glycation End Products‐Blocking Antibody to Treat Diabetic Peripheral Artery Disease
- DOI
- 10.1161/jaha.120.016696
- Published
- 2021-01-05
- Container
- Journal of the American Heart Association
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1161/jaha.120.016696,
title = {Novel Receptor for Advanced Glycation End Products‐Blocking Antibody to Treat Diabetic Peripheral Artery Disease},
author = {Lynne L. Johnson and Jordan Johnson and Rebecca Ober and April Holland and Geping Zhang and Marina Backer and Joseph Backer and Ziad Ali and Yared Tekabe},
year = {2021},
journal = {Journal of the American Heart Association},
doi = {10.1161/jaha.120.016696},
url = {https://doi.org/10.1161/jaha.120.016696}
}RIS
TY - JOUR TI - Novel Receptor for Advanced Glycation End Products‐Blocking Antibody to Treat Diabetic Peripheral Artery Disease AU - Lynne L. Johnson AU - Jordan Johnson AU - Rebecca Ober AU - April Holland AU - Geping Zhang AU - Marina Backer AU - Joseph Backer AU - Ziad Ali AU - Yared Tekabe PY - 2021 JO - Journal of the American Heart Association DO - 10.1161/jaha.120.016696 UR - https://doi.org/10.1161/jaha.120.016696 ER -
APA
Johnson, L. L., Johnson, J., Ober, R., Holland, A., Zhang, G., Backer, M., Backer, J., Ali, Z., & Tekabe, Y. (2021). Novel Receptor for Advanced Glycation End Products‐Blocking Antibody to Treat Diabetic Peripheral Artery Disease. Journal of the American Heart Association. https://doi.org/10.1161/jaha.120.016696
Source records
- crossref · retrieved 2026-09-27T00:19:03.332Z